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Diarrheal risk associated with Plesiomonas shigelloides 
infection was assessed in rural communities in northwestern 
Ecuador during 2004–2008. We found little evidence 
that single infection with P. shigelloides is associated 
with diarrhea but stronger evidence that co-infection with 
rotavirus causes diarrhea.
P
lesiomonas shigelloides (family Enterobacteriaceae) 
has been implicated in gastroenteritis outbreaks in 
travelers to tropical regions and in persons who have 
ingested contaminated food or water (1–3). For persons 
native to tropical regions, however, case–control studies 
have found little or no association between P. shigelloides 
infection and diarrhea (4–6). Although these studies 
have been conducted in areas where mixed infections are 
generally common, to our knowledge, none examined co-
infections. We assessed the pathogenicity of P. shigelloides 
in the context of co-infections and across all age groups in 
a province in northwestern Ecuador.
The Study
During 2004–2008, serial case–control studies were 
conducted in 22 remote communities in Esmeraldas 
Province, Ecuador. Complete study design and laboratory 
procedures for pathogen detection have been described (7). 
Brieﬂ  y, each community was visited 4–6 times on a rotating 
basis; each visit lasted for 15 days, during which all cases of 
diarrhea were identiﬁ  ed by a visit to each household every 
morning. Household residents with cases had >3 loose 
stools in a 24-hour period, and controls had no symptoms 
of diarrhea during the past 6 days. Fecal samples were 
collected from 3 healthy controls per person with diarrhea. 
These samples were plated on selective agar media, and 
5 lactose-fermenting colonies were screened by PCR for 
enterotoxigenic Escherichia coli (ETEC), enteropathogenic 
E. coli, and enteroinvasive E. coli (EIEC). Lactose-negative 
isolates that were identiﬁ  ed as either Shigella spp. or E. coli 
were also screened by PCR for the same molecular marker 
used for EIEC. All non–lactose-fermenting pathogens, 
including  P. shigelloides, were biochemically identiﬁ  ed 
by API 20E system (bioMèrieux, Marey l’Etoile, France). 
Because shigellae are phylogenetically similar to E. coli 
pathotypes, we combined data from persons infected with 
E. coli and those infected with shigellae in our analysis. 
We tested for Giardia lamblia by using an ELISA kit 
(RIDASCREEN  Giardia; R-Biopharm, Darmstadt, 
Germany), and rotavirus was detected with an enzyme 
immunoassay kit (RIDA Quick Rotavirus; R-Biopharm). 
We chose a molecular method for detecting E. coli 
pathotypes because they cannot be differentiated solely on 
the basis of biochemical tests; the metabolic homogeneity 
of P. shigelloides, however, makes this organism easily 
and clearly identiﬁ   able by biochemical test. Similarly, 
immunologic methods used for Giardia sp. and rotavirus 
detection are speciﬁ  c and sensitive enough to accurately 
detect these pathogens, and use of molecular methods 
would be justiﬁ  ed only for deeper analysis. Institutional 
review board committees at the University of California, 
Berkeley; University of Michigan; Trinity College; and 
Universidad San Francisco de Quito approved all protocols.
During March 2004–March 2008, a total of 2,936 
fecal samples were collected from persons of all ages (168 
[6%] were <1 year of age, 597 [20%] were 1–4 years, 
753 [26%] were 5–12 years, 1,362 [46%] were >13 years, 
and 56 [2%] were missing a birth date), corresponding to 
775 cases and 2,161 controls. P. shigelloides was isolated 
in 253 (8.6%) samples. This number exceeded isolation 
rates for all of the pathogens analyzed except G. lamblia, 
which was present in 701 (23.9%) samples. Rotavirus 
was detected in 225 (7.7%) samples and EIEC/shigellae 
in 188 (6.4%) samples. P. shigelloides was detected in 
11.4% of case-patients with diarrhea (case prevalence), 
which is more than the 7.2% estimated in the community 
(weighted control prevalence; Figure). However, once we 
stratiﬁ  ed by persons infected only with P. shigelloides and 
those infected with P. shigelloides plus >1 of the other 
marker pathogens for which we tested, single infections 
with  P. shigelloides were almost equally prevalent in 
the case-patients and in the community; in contrast, co-
infections with P. shigelloides and other pathogens were 
more frequent in persons with diarrhea (Figure).
To determine whether P. shigelloides infection was 
associated with diarrhea, we estimated risk ratios (RRs) 
and bootstrapped 95% CIs for single and co-infection 
exposures (Table). A single infection with P. shigelloides 
was not associated with diarrhea (RR 1.5, 95% CI 0.9–
2.2). Persons co-infected with P. shigelloides and another 
pathogen, however, had almost 6× the risk for diarrhea 
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than those with no infection (RR 5.6, 95% CI 3.5–9.3) and 
simultaneous occurrence of P. shigelloides and rotavirus 
increased the risk for diarrhea to 16.2 (Table). We found 
no evidence for confounding of the association between 
P. shigelloides and diarrhea by co-infecting pathogens 
(RRcrude = RRMH-pooled; where RRcrude is the unadjusted RR 
and RRMH-pooled is the pooled Mantel-Haenszel RR estimate). 
However, we found some evidence for confounding by age 
of  P. shigelloides co-infection (RRMH-pooled 4.2 [95% CI 
2.1–8.1], compared with the crude estimate of 5.6) but no 
evidence for confounding by age for single infection with 
P. shigelloides.
Conclusions
A single infection with P. shigelloides resulted in 
a moderately increased risk for diarrheal disease, which 
suggests that this microorganism plays a minor role as a 
pathogen. This result agrees with ﬁ   ndings of previous 
studies (4,8,9). Analysis of the co-infections, however, 
suggests that P. shigelloides may be pathogenic in the 
presence of another pathogen. Speciﬁ  cally, co-infections of 
P. shigelloides with either rotavirus or pathogenic E. coli 
(including shigellae) were 16.2× (95% CI 5.5–62.3) and 
13.8× (95% CI 3.3–69.3) more likely to result in diarrhea, 
respectively. We cannot, therefore, rule out the pathogenic 
capacity of P. shigelloides even though single infection 
may not be sufﬁ  cient to cause disease.
This co-infection analysis might be limited by the 
number of pathogens considered (Giardia sp., rotavirus, 
pathogenic  E. coli, and shigellae). However, the high 
isolation rates suggest we are detecting the major pathogens 
in the region. Other pathogens that may be useful to 
consider, given their attention in the literature, include 
Entaemobae histolytica and Cryptosporidium spp.
Although we found nothing in the literature that 
addresses the role of co-infection in the pathogenicity of 
P. shigelloides, co-infection with enteric pathogens is a 
well-known phenomenon, especially in tropical regions 
(6). Co-infection with ETEC and enteropathogenic E. coli 
increases virulence (10). Other studies have shown that the 
severity of disease is increased when rotavirus infections 
occur alongside another infection with another enteric 
pathogen (11).
P. shigelloides may take advantage of the disruption of 
the normal gut microbiota and gut physiology because of 
the concurrent presence of other pathogens, establishing a 
pathology in the human gut. For example, diarrhea caused 
by enterotoxins produced by pathogens, such as ETEC, and 
Vibrio cholerae (12), may remove normal gut microbiota, 
enabling  P. shigelloides to establish an infection. The 
disruption of gut microbiota that facilitates gut colonization 
has been demonstrated in murine models infected with 
Citrobacter rodentium and Salmonella enterica serovar 
Typhimurium (13).
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Figure. Case prevalence (black) and 
weighted community prevalence (white) 
of enteric pathogens, Ecuador, 2004–
2008. Identiﬁ   cation of pathogenic 
Escherichia coli was based on the 
genes given in parentheses. EIEC, 
enteroinvasive  E. coli; Ipah, invasion 
plasmid antigen gene; ETEC, entero-
toxigenic  E. coli; LT, heat-labile 
toxin; ST, heat-stable toxin; EPEC, 
enteropathogenic  E. coli; bfp, bundle-
forming pili.
Table. RRs and bootstrapped 95% CIs for single infections and co-infections with Plesiomonas shigelloides, Ecuador, 2004–2008* 
Co-infection RRSingle P.shig (95% CI)  RRCo-Infection (95% CI) RRCrude (95% CI) RRMH-Pooled (95% CI) 
Wald test for 
heterogeneity p  value 
Any pathogen  1.5 (0.9–2.2)  5.6 (3.5–9.3)  2.6 (1.9–3.5)  2.7 (1.9–3.6)  32.1  <0.001 
Rotavirus  1.5 (0.9–2.2)  16.2 (5.5–62.3)  1.7 (1.1–2.5)  1.9 (1.2–2.9)  61.8  <0.001 
Giardia sp. 1.5 (0.9–2.2)  2.1 (1.0–3.9)  1.5 (1.0–2.2)  1.6 (1.1–2.3)  1.3  0.2 
Escherichia coli/
shigellae
1.5 (0.9–2.2)  13.8 (3.3–69.3)  1.6 (1.1–2.4)  1.7 (1.1–2.6)  32.8  <0.001 
*RR, risk ratio. RRcrude = the unadjusted RR and RRMH-pooled is the pooled Mantel-Haenszel RR ratio estimate. The Wald test assesses whether the strata 
RRSingle P.shig and RRco-infection differ. Because of the clustered study design and the unequal sampling probabilities of controls, we chose not to use logistic
regression models. Instead, we applied a nonparametric approach by using sampling weights to estimate RRs, as one would for a cohort study. We 
bootstrapped 1,000 samples from the original dataset, and with each new sample, we estimated the RR associated with single infection and co-infection. 
The lower 0.025 and upper 0.975 percentiles of the bootstrap distribution are reported as 95% CIs. Statistical analyses were conducted by using R 
version 2.11.1 (www.r-project.org). Most medical literature considers infectious diarrhea 
as a monopathogenic phenomenon (12,14). In the 
data presented here, the crude risk ratio suggests that 
P. shigelloides is pathogenic. When looking at single 
infections, we found no evidence that P. shigelloides is 
pathogenic. When looking at co-infection data, however, 
we found associations between infection and diarrhea. Our 
ﬁ  ndings suggest that multipathogenic infections may play a 
role in the pathogenesis of infectious diarrhea.
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